Tim Luetkens
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 30
- Multiple Myeloma Research and Treatments 27
- Oncology 23
- CAR-T cell therapy research 17
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Djordje Atanackovic (58 shared papers)Nicolaus Martin Kröger (21 shared papers)Carsten Bokemeyer (19 shared papers)Sabarinath Venniyil Radhakrishnan (13 shared papers)Katrin Bartels (16 shared papers)York Hildebrandt (16 shared papers)Yanran Cao (14 shared papers)Sebastian Kobold (10 shared papers)
- Journals
- Blood (5 papers)Haematologica (4 papers)Human Vaccines & Immunotherapeutics (4 papers)Leukemia (3 papers)OncoImmunology (3 papers)
- Partner nations
- United StatesGermanyNigeria
In The Last Decade
Tim Luetkens
67 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 73
- Hematology 577
- Oncology 662
- Immunology 350
- Biological Psychiatry 10
- Behavioral Neuroscience 20
Countries citing papers authored by Tim Luetkens
This map shows the geographic impact of Tim Luetkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Luetkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Luetkens more than expected).
Fields of papers citing papers by Tim Luetkens
This network shows the impact of papers produced by Tim Luetkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Luetkens. The network helps show where Tim Luetkens may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Luetkens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 110 | |
| 2 | 2011 | 98 | |
| 3 | 2013 | 94 | |
| 4 | 2009 | 88 | |
| 5 | 2022 | 88 | |
| 6 | 2015 | 85 | |
| 7 | 2010 | 78 | |
| 8 | 2009 | 70 | |
| 9 | 2009 | 66 | |
| 10 | 2020 | 66 | |
| 11 | 2020 | 66 | |
| 12 | 2008 | 58 | |
| 13 | 2009 | 56 | |
| 14 | 2016 | 55 | |
| 15 | 2014 | 51 | |
| 16 | 2010 | 48 | |
| 17 | 2010 | 41 | |
| 18 | 2014 | 39 | |
| 19 | 2016 | 38 | |
| 20 | 2010 | 32 |
About Tim Luetkens
Tim Luetkens is a scholar working on Hematology, Oncology, Immunology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 69 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), T-cell and B-cell Immunology (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (577 citations), Oncology (662 citations), Immunology (350 citations), Biological Psychiatry (10 citations) and Behavioral Neuroscience (20 citations). Tim Luetkens has collaborated with scholars based in United States, Germany and Nigeria. Frequent co-authors include Djordje Atanackovic, Nicolaus Martin Kröger, Carsten Bokemeyer, Sabarinath Venniyil Radhakrishnan, Katrin Bartels, York Hildebrandt, Yanran Cao, Sebastian Kobold, Michael Olson and Mary Nicole Steinbach. Their work appears in journals such as Blood, Haematologica, Human Vaccines & Immunotherapeutics, Leukemia and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.